Skip to main content
Philip Saylor, MD, Oncology, Boston, MA, Massachusetts General Hospital

PhilipJamesSaylorMD

Oncology Boston, MA

Genitourinary Oncology, Hematologic Oncology

Assistant Professor of Medicine, Massachusetts General Hospital

Dr. Saylor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Saylor's full profile

Already have an account?

Summary

  • Dr. Philip Saylor is an oncologist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from University of Pittsburgh School of Medicine and has been in practice 14 years. He specializes in genitourinary oncology and hematologic oncology and is experienced in amyloidosis, hematologic oncology, prostate cancer, myelodysplasia, and myelofibrosis.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2007 - 2010
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Internal Medicine, 2003 - 2006
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 2003

Certifications & Licensure

  • ME State Medical License
    ME State Medical License 2020 - 2025
  • MA State Medical License
    MA State Medical License 2008 - 2025
  • CA State Medical License
    CA State Medical License 2005 - 2025
  • NH State Medical License
    NH State Medical License 2021 - 2025
  • RI State Medical License
    RI State Medical License 2021 - 2024
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Outside the Guidelines: Denosumab Overuse in Prostate Cancer
    Outside the Guidelines: Denosumab Overuse in Prostate CancerMarch 7th, 2024
  • SUO 2023: Bone Support Throughout the Prostate Cancer Journey
    SUO 2023: Bone Support Throughout the Prostate Cancer JourneyNovember 30th, 2023

Professional Memberships

Hospital Affiliations